Нумерология      Карма      Читалня      Ошо      Рецепти      Здраве      Луиз Хей    
   Астрология      Езотерика      Телепатия      Крион      Бог, Уолш      Чакри      Съновник      Психология      RSS

Лунни Възли
Хороскопи
Зодии
Натална
Синастрия
Съвместимост
Предсказателна
Ерогенни зони
Любов и Секс
Сексуалност
Еротика
Любовен Хороскоп
Тя и Той
Духовно Израстване


Начало  Регистрация  Вход


Ченълинги
Книги
Сентенции
Вампиризъм
Нумерология en
The Arcturians
Приказки
Супер Игри
Софтуер | Линкове
Музика | Филми
Благодарност
Игри | Таро
Отзиви
Lifestyle (2) (3)
(4) (5) (6) (7)
Business, Careers
(2) (3) (4) (5)
The 9th D


00:51
17.08.2017
Четвъртък
54.225.16.58


Онлайн: 4
Гости: 4
Потребители: 0


 Пими ® » Ошо » Business » Topamax (Topiramate) - Indications and Dosage

Ошо [13]Ошо - Тук и сега [5]
Ошо - За зрелостта [9]Ошо - За смелостта [13]
Ошо - За творчеството [9]Ошо - За медитацията [8]
Ошо - Кундалини и чакрите [12]Ошо - Книга на тайните [19]
Ошо - Следвай ме [1]Ошо - Възгледът за Тантра [11]
Ошо - ДАО. Трите Съкровища [36]Ошо - Медитация. Изкуството на екстаза [26]
Ошо - Трансформация на седемте тела [9]Ошо - Дарът на Атиша [8]
Ошо - Библия [4]Business [40]


Topamax (Topiramate) - Indications and Dosage

INDICATIONS AND USAGE Monotherapy Epilepsy

TOPAMAX® (topiramate) Tablets and TOPAMAX® (topiramate capsules) Sprinkle Capsules are indicated as initial monotherapy in patients 10 years of age and older with partial onset or primary generalized tonic-clonic seizures.

Effectiveness was demonstrated in a controlled trial in patients with epilepsy who had no more than 2 seizures in the 3 months prior to enrollment. Safety and effectiveness in patients who were converted to monotherapy from a previous regimen of other anticonvulsant drugs have not been established in controlled trials.

Adjunctive Therapy Epilepsy

TOPAMAX® (topiramate) Tablets and TOPAMAX® (topiramate capsules) Sprinkle Capsules are indicated as adjunctive therapy for adults and pediatric patients ages 2 - 16 years with partial onset seizures, or primary generalized tonic-clonic seizures, and in patients 2 years of age and older with seizures associated with Lennox-Gastaut syndrome.

Migraine

TOPAMAX® (topiramate) Tablets and TOPAMAX® (topiramate capsules) Sprinkle Capsules are indicated for adults for the prophylaxis of migraine headache. The usefulness of TOPAMAX® in the acute treatment of migraine headache has not been studied.

DOSAGE AND ADMINISTRATION

Epilepsy

In the controlled add-on trials, no correlation has been demonstrated between trough plasma concentrations of topiramate and clinical efficacy. No evidence of tolerance has been demonstrated in humans. Doses above 400 mg/day (600, 800, or 1,000 mg/day) have not been shown to improve responses in dose-response studies in adults with partial onset seizures.

It is not necessary to monitor topiramate plasma concentrations to optimize TOPAMAX® therapy. On occasion, the addition of TOPAMAX® to phenytoin may require an adjustment of the dose of phenytoin to achieve optimal clinical outcome. Addition or withdrawal of phenytoin and/or carbamazepine during adjunctive therapy with TOPAMAX® may require adjustment of the dose of TOPAMAX®. Because of the bitter taste, tablets should not be broken.

TOPAMAX® can be taken without regard to meals.

Monotherapy Use

The recommended dose for topiramate monotherapy in adults and children 10 years of age and older is 400 mg/day in two divided doses. Approximately 58% of patients randomized to 400 mg/day achieved this maximal dose in the monotherapy controlled trial; the mean dose achieved in the trial was 275 mg/day. The dose should be achieved by titrating according to the following schedule:


Morning DoseEvening Dose
Week 125 mg25 mg
Week 250 mg50 mg
Week 375 mg75 mg
Week 4100 mg100 mg
Week 5150 mg150 mg
Week 6200 mg200 mg

Adjunctive Therapy Use

Adults (17 Years of Age and Over) - Partial Seizures, Primary Generalized Tonic-Clonic Seizures, or Lennox-Gastaut Syndrome

The recommended total daily dose of TOPAMAX® as adjunctive therapy in adults with partial seizures is 200-400 mg/day in two divided doses, and 400 mg/day in two divided doses as adjunctive treatment in adults with primary generalized tonic-clonic seizures. It is recommended that therapy be initiated at 25-50 mg/day followed by titration to an effective dose in increments of 25-50 mg/week. Titrating in increments of 25 mg/week may delay the time to reach an effective dose. Daily doses above 1,600 mg have not been studied.

In the study of primary generalized tonic-clonic seizures the initial titration rate was slower than in previous studies; the assigned dose was reached at the end of 8 weeks (see CLINICAL STUDIES, Adjunctive Therapy Controlled Trials in Patients With Primary Generalized Tonic-Clonic Seizures ).

Pediatric Patients (Ages 2 - 16 Years)– Partial Seizures, Primary Generalized Tonic-Clonic Seizures, or Lennox-Gastaut Syndrome

The recommended total daily dose of TOPAMAX® (topiramate) as adjunctive therapy for patients with partial seizures, primary generalized tonic-clonic seizures, or seizures associated with Lennox-Gastaut syndrome is approximately 5 to 9 mg/kg/day in two divided doses. Titration should begin at 25 mg (or less, based on a range of 1 to 3 mg/kg/day) nightly for the first week. The dosage should then be increased at 1- or 2-week intervals by increments of 1 to 3 mg/kg/day (administered in two divided doses), to achieve optimal clinical response. Dose titration should be guided by clinical outcome.

In the study of primary generalized tonic-clonic seizures the initial titration rate was slower than in previous studies; the assigned dose of 6 mg/kg/day was reached at the end of 8 weeks (see CLINICAL STUDIES, Adjunctive Therapy Controlled Trials in Patients With Primary Generalized Tonic-Clonic Seizures ).

Migraine

The recommended total daily dose of TOPAMAX® as treatment for prophylaxis of migraine headache is 100 mg/day administered in two divided doses. The recommended titration rate for topiramate for migraine prophylaxis to 100 mg/day is:

 Morning DoseEvening Dose
Week 1None25 mg
Week 225 mg25 mg
Week 325 mg50 mg
Week 450 mg50 mg

Dose and titration rate should be guided by clinical outcome. If required, longer intervals between dose adjustments can be used.

Administration of TOPAMAX® Sprinkle Capsules

TOPAMAX® (topiramate capsules) Sprinkle Capsules may be swallowed whole or may be administered by carefully opening the capsule and sprinkling the entire contents on a small amount (teaspoon) of soft food. This drug/food mixture should be swallowed immediately and not chewed. It should not be stored for future use.

Patients with Renal Impairment:

In renally impaired subjects (creatinine clearance less than 70 mL/min/1.73 m2), one half of the usual adult dose is recommended. Such patients will require a longer time to reach steady-state at each dose.

Geriatric Patients (Ages 65 Years and Over):

Dosage adjustment may be indicated in the elderly patient when impaired renal function (creatinine clearance rate≤70 mL/min/1.73 m2) is evident (see DOSAGE AND ADMINISTRATION: Patients with Renal Impairment and CLINICAL PHARMACOLOGY: Special Populations: Age, Gender, and Race ).

Patients Undergoing Hemodialysis:

Topiramate is cleared by hemodialysis at a rate that is 4 to 6 times greater than a normal individual. Accordingly, a prolonged period of dialysis may cause topiramate concentration to fall below that required to maintain an anti-seizure effect. To avoid rapid drops in topiramate plasma concentration during hemodialysis, a supplemental dose of topiramate may be required. The actual adjustment should take into account 1) the duration of dialysis period, 2) the clearance rate of the dialysis system being used, and 3) the effective renal clearance of topiramate in the patient being dialyzed.

Patients with Hepatic Disease:

In hepatically impaired patients topiramate plasma concentrations may be increased. The mechanism is not well understood.

HOW SUPPLIED

TOPAMAX® (topiramate) Tablets are available as debossed, coated, round tablets in the following strengths and colors:

25 mg white (coded "TOP" on one side; "25" on the other)
50 mg light-yellow (coded "TOPAMAX" on one side; "50" on the other)
100 mg yellow (coded "TOPAMAX" on one side; "100" on the other)
200 mg salmon (coded "TOPAMAX" on one side; "200" on the other)

They are supplied as follows:
25 mg tablets – bottles of 60 count with desiccant (NDC 0045-0639-65)
50 mg tablets – bottles of 60 count with desiccant (NDC 0045-0640-65)
100 mg tablets – bottles of 60 count with desiccant (NDC 0045-0641-65)
200 mg tablets – bottles of 60 count with desiccant (NDC 0045-0642-65)

TOPAMAX® (topiramate capsules) Sprinkle Capsules contain small, white to off white spheres. The gelatin capsules are white and clear.

They are marked as follows:
15 mg capsule with "TOP” and "15 mg” on the side
25 mg capsule with "TOP” and "25 mg” on the side

The capsules are supplied as follows:
15 mg capsules – bottles of 60 (NDC 0045-0647-65)
25 mg capsules – bottles of 60 (NDC 0045-0645-65)

TOPAMAX® (topiramate) Tablets should be stored in tightly-closed containers at controlled room temperature (59 to 86°F, 15 to 30°C). Protect from moisture.

TOPAMAX® (topiramate capsules) Sprinkle Capsules should be stored in tightly-closed containers at or below 25°C (77°F). Protect from moisture.

TOPAMAX® (topiramate) and TOPAMAX® (topiramate capsules) are trademarks of Ortho-McNeil Neurologics, Inc.

TOPAMAX® (topiramate) and TOPAMAX® (topiramate capsules) are manufactured by Janssen Ortho, LLC Gurabo, Puerto Rico 00778 for Ortho-McNeil Neurologics, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc. Titusville, NJ 08560.

Папка: Business | Посещения: 3667 | Ченълинги | The Arcturians

Ошо [13]Ошо - Тук и сега [5]
Ошо - За зрелостта [9]Ошо - За смелостта [13]
Ошо - За творчеството [9]Ошо - За медитацията [8]
Ошо - Кундалини и чакрите [12]Ошо - Книга на тайните [19]
Ошо - Следвай ме [1]Ошо - Възгледът за Тантра [11]
Ошо - ДАО. Трите Съкровища [36]Ошо - Медитация. Изкуството на екстаза [26]
Ошо - Трансформация на седемте тела [9]Ошо - Дарът на Атиша [8]
Ошо - Библия [4]Business [40]
Business Astrala /// College, Universities / loans | Business | Business-Bankruptcy | College | Business, Careers (2) (3) (4) (5) / Business / College, Universities, Careers / Business / College /// Business / College /// College / Business

Please Donate To Bitcoin Address: [[address]]

Donation of [[value]] BTC Received. Thank You.
[[error]]

Контакт          54.225.16.58